Report Detail

Other Global Fosfomycin Trometamol Market Growth 2019-2024

  • RnM2938410
  • |
  • 13 February, 2019
  • |
  • Global
  • |
  • 131 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform.
Mainly for the treatment of urinary tract infections such as cystitis, urethritis.

In the last several years, global market of fosfomycin trometamol developed smoothly, with an average growth rate of 7.8%. In 2015, global revenue of fosfomycin trometamol is nearly 44 million usd; the actual production is about 354 MT.

the global average price of fosfomycin trometamol is in the decreasing trend, from 131 USD /kg in 2011 to 124 USD/kg in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years.

the classification of fosfomycin trometamol includes fosfomycin tromethamine granules and fosfomycin tromethamine powder, and the proportion of fosfomycin tromethamine granules in 2015 is about 56%.fosfomycin trometamol is widely used in urinary tract infection.

china is the largest supplier of fosfomycin trometamol, with a production market share nearly 83% in 2015. europe is the second largest supplier of fosfomycin trometamol, enjoying production market share nearly 15% in 2015.

north america is the largest consumption place, with a consumption market share nearly 36% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 31%. China is the world's largest exporting country.

market competition is not intense. Zambon and northesat pharm, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Fosfomycin Trometamol market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 58 million by 2024, from US$ 48 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Fosfomycin Trometamol business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Fosfomycin Trometamol market by product type, application, key manufacturers and key regions and countries.

This study considers the Fosfomycin Trometamol value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Fosfomycin Tromethamine Granules
Fosfomycin Tromethamine Powder
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Common Urinary Tract Infection
Postoperative Urinary Tract Infection
Preoperative Prevention of Urinary Tract Infection

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Zambon
Northesat Pharm
Hunan Huana Pharmaceuticals
Xunda Pharma
FarmaSino Pharmaceutical
Guilin Hwasun
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Fosfomycin Trometamol consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fosfomycin Trometamol market by identifying its various subsegments.
Focuses on the key global Fosfomycin Trometamol manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fosfomycin Trometamol with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Fosfomycin Trometamol submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Fosfomycin Trometamol Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Fosfomycin Trometamol Consumption 2014-2024
        • 2.1.2 Fosfomycin Trometamol Consumption CAGR by Region
      • 2.2 Fosfomycin Trometamol Segment by Type
        • 2.2.1 Fosfomycin Tromethamine Granules
        • 2.2.2 Fosfomycin Tromethamine Powder
      • 2.3 Fosfomycin Trometamol Consumption by Type
        • 2.3.1 Global Fosfomycin Trometamol Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Fosfomycin Trometamol Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Fosfomycin Trometamol Sale Price by Type (2014-2019)
      • 2.4 Fosfomycin Trometamol Segment by Application
        • 2.4.1 Common Urinary Tract Infection
        • 2.4.2 Postoperative Urinary Tract Infection
        • 2.4.3 Preoperative Prevention of Urinary Tract Infection
      • 2.5 Fosfomycin Trometamol Consumption by Application
        • 2.5.1 Global Fosfomycin Trometamol Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Fosfomycin Trometamol Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Fosfomycin Trometamol Sale Price by Application (2014-2019)

      3 Global Fosfomycin Trometamol by Players

      • 3.1 Global Fosfomycin Trometamol Sales Market Share by Players
        • 3.1.1 Global Fosfomycin Trometamol Sales by Players (2017-2019)
        • 3.1.2 Global Fosfomycin Trometamol Sales Market Share by Players (2017-2019)
      • 3.2 Global Fosfomycin Trometamol Revenue Market Share by Players
        • 3.2.1 Global Fosfomycin Trometamol Revenue by Players (2017-2019)
        • 3.2.2 Global Fosfomycin Trometamol Revenue Market Share by Players (2017-2019)
      • 3.3 Global Fosfomycin Trometamol Sale Price by Players
      • 3.4 Global Fosfomycin Trometamol Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Fosfomycin Trometamol Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Fosfomycin Trometamol Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Fosfomycin Trometamol by Regions

      • 4.1 Fosfomycin Trometamol by Regions
        • 4.1.1 Global Fosfomycin Trometamol Consumption by Regions
        • 4.1.2 Global Fosfomycin Trometamol Value by Regions
      • 4.2 Americas Fosfomycin Trometamol Consumption Growth
      • 4.3 APAC Fosfomycin Trometamol Consumption Growth
      • 4.4 Europe Fosfomycin Trometamol Consumption Growth
      • 4.5 Middle East & Africa Fosfomycin Trometamol Consumption Growth

      5 Americas

      • 5.1 Americas Fosfomycin Trometamol Consumption by Countries
        • 5.1.1 Americas Fosfomycin Trometamol Consumption by Countries (2014-2019)
        • 5.1.2 Americas Fosfomycin Trometamol Value by Countries (2014-2019)
      • 5.2 Americas Fosfomycin Trometamol Consumption by Type
      • 5.3 Americas Fosfomycin Trometamol Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Fosfomycin Trometamol Consumption by Countries
        • 6.1.1 APAC Fosfomycin Trometamol Consumption by Countries (2014-2019)
        • 6.1.2 APAC Fosfomycin Trometamol Value by Countries (2014-2019)
      • 6.2 APAC Fosfomycin Trometamol Consumption by Type
      • 6.3 APAC Fosfomycin Trometamol Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Fosfomycin Trometamol by Countries
        • 7.1.1 Europe Fosfomycin Trometamol Consumption by Countries (2014-2019)
        • 7.1.2 Europe Fosfomycin Trometamol Value by Countries (2014-2019)
      • 7.2 Europe Fosfomycin Trometamol Consumption by Type
      • 7.3 Europe Fosfomycin Trometamol Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Fosfomycin Trometamol by Countries
        • 8.1.1 Middle East & Africa Fosfomycin Trometamol Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Fosfomycin Trometamol Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Fosfomycin Trometamol Consumption by Type
      • 8.3 Middle East & Africa Fosfomycin Trometamol Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Fosfomycin Trometamol Distributors
      • 10.3 Fosfomycin Trometamol Customer

      11 Global Fosfomycin Trometamol Market Forecast

      • 11.1 Global Fosfomycin Trometamol Consumption Forecast (2019-2024)
      • 11.2 Global Fosfomycin Trometamol Forecast by Regions
        • 11.2.1 Global Fosfomycin Trometamol Forecast by Regions (2019-2024)
        • 11.2.2 Global Fosfomycin Trometamol Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Fosfomycin Trometamol Forecast by Type
      • 11.8 Global Fosfomycin Trometamol Forecast by Application

      12 Key Players Analysis

      • 12.1 Zambon
        • 12.1.1 Company Details
        • 12.1.2 Fosfomycin Trometamol Product Offered
        • 12.1.3 Zambon Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Zambon News
      • 12.2 Northesat Pharm
        • 12.2.1 Company Details
        • 12.2.2 Fosfomycin Trometamol Product Offered
        • 12.2.3 Northesat Pharm Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Northesat Pharm News
      • 12.3 Hunan Huana Pharmaceuticals
        • 12.3.1 Company Details
        • 12.3.2 Fosfomycin Trometamol Product Offered
        • 12.3.3 Hunan Huana Pharmaceuticals Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Hunan Huana Pharmaceuticals News
      • 12.4 Xunda Pharma
        • 12.4.1 Company Details
        • 12.4.2 Fosfomycin Trometamol Product Offered
        • 12.4.3 Xunda Pharma Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Xunda Pharma News
      • 12.5 FarmaSino Pharmaceutical
        • 12.5.1 Company Details
        • 12.5.2 Fosfomycin Trometamol Product Offered
        • 12.5.3 FarmaSino Pharmaceutical Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 FarmaSino Pharmaceutical News
      • 12.6 Guilin Hwasun
        • 12.6.1 Company Details
        • 12.6.2 Fosfomycin Trometamol Product Offered
        • 12.6.3 Guilin Hwasun Fosfomycin Trometamol Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Guilin Hwasun News

      ...

        13 Research Findings and Conclusion

        Summary:
        Get latest Market Research Reports on Fosfomycin Trometamol . Industry analysis & Market Report on Fosfomycin Trometamol is a syndicated market report, published as Global Fosfomycin Trometamol Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Fosfomycin Trometamol market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,660.00
        $5,490.00
        $7,320.00
        2,924.34
        4,386.51
        5,848.68
        3,400.14
        5,100.21
        6,800.28
        570,264.60
        855,396.90
        1,140,529.20
        305,756.40
        458,634.60
        611,512.80
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report